IntroductionIL-15 is a member of the common ␥-chain family of cytokines and was initially characterized as a T-cell proliferation factor. 1,2 IL-15 is a growth, mobilization, and activation factor for important lymphocyte populations, including NK, CD8, and intraepithelial lymphocytes. 3-6 IL-15 and IL-2 share the same IL-2/IL-15␥ receptor (IL-2/IL-15R␥), 7 but their biologic effects at the level of organism are different, as shown by studies in knockout mice. The lack of IL-15 in vivo results in severe defects in the development and function of the immune system. 8,9 Although lymphocytes from IL-2 knockout mice fail to proliferate in response to polyclonal T-cell mitogens in vitro, 10 the common features developing in these mice are lymphocyte activation and autoimmunity. 11 In humans, IL-2-receptor ␣ (IL-2R␣) deficiency has been linked to a paradoxical combination of immunodeficiency and autoimmunity in 2 patients. 12,13 The biologic differences of IL-2 and IL-15 are determined by their different production sites, 5,14 their strength of association with the membrane proteins IL-2R␣ and IL-15R␣, 15 respectively, and the regulation of these receptor molecules. IL-2 is produced by activated lymphocytes, whereas IL-15 is produced by stromal cells of several tissues, and by antigen-presenting cells. IL-15R␣ has a high affinity for IL-15 (K d ϳ 10 Ϫ11 M). 15 In contrast, IL-2R␣ has lower affinity for IL-2 (K d ϳ 10 Ϫ8 M) and is expressed mainly on activated T cells and persistently on Treg.IL-15 is known to act on the surface of the cell in complex with IL-15R␣ to engage the IL-2/IL-15R␥ complex in nearby cells, a process termed trans-presentation. 16 Genetic and cell transfer experiments have shown that IL-15 and IL-15R␣ need to reside in the same cell for appropriate function. [17][18][19][20] We previously demonstrated that coexpression of the 2 molecules in the same cell leads to rapid intracellular association of IL-15 and IL-15R␣ in the endoplasmic reticulum, stabilization of both molecules, and the generation of a stable complex that can translocate to the cell membrane, where it is bioactive. 21,22 In addition, the surface heterodimer is rapidly cleaved and released in the plasma as bioactive cytokine. 22 Our experiments using IL-15 complexed to a C-terminal deletion of IL-15R␣ containing only the soluble extracellular fragment demonstrated that this complex is bioactive in vivo in the absence of any membrane-bound form of IL-15. 22 These results explain the necessity for the coordinate expression of IL-15 and IL-15R␣ in the same cell for physiologic function, [17][18][19] and predict that the circulating form of IL-15 in biologic fluids is in complex with soluble IL-15R␣ (sIL-15R␣).Although these results suggested that the main bioactive form of IL-15 is in a complex with IL-15R␣, 21-26 the actual form of IL-15 produced in humans has not been identified. The levels of IL-15 in normal human serum are close to the limit of detection of the existing assay (ϳ 1 pg/mL). Therefore, we studied the nature of the...